Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

<p>Supplementary Figure 1: Study flow-chart. Supplementary Figure 2: Kaplan-Meier curves of event-free survival according to tertile-split tumor mutational burden. Supplementary Figure 3. Kaplan-Meier curves of recurrence-free survival according to the molecular subtype. Supplementary Figure 4...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Giuseppe Basile (15051269) (author)
Weitere Verfasser: Marco Bandini (15051272) (author), Ewan A. Gibb (15051275) (author), Jeffrey S. Ross (15030824) (author), Daniele Raggi (15051278) (author), Laura Marandino (15051281) (author), Tiago Costa de Padua (15051284) (author), Emanuele Crupi (15051287) (author), Renzo Colombo (15051290) (author), Maurizio Colecchia (15051293) (author), Roberta Lucianò (15051296) (author), Luigi Nocera (15051299) (author), Marco Moschini (15051302) (author), Alberto Briganti (15051305) (author), Francesco Montorsi (15051308) (author), Andrea Necchi (15044772) (author)
Veröffentlicht: 2025
Schlagworte:
Cancer
Immuno-oncology
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Genitourinary Cancers
Bladder cancer
Immunotherapy
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge